7Baggers

We provide you with 20 years of free, institutional-grade data for PTCT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PTCT. Explore the full financial landscape of PTCT stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$7,686,108
NameActionSharesAvg PriceAmountReported Date
Reeve EmmaDerivatives Exercise10,8372025-09-16
Reeve EmmaSale-15,705$59.5$934,4482025-09-16
Boulding Mark ElliottSale-47,249$61$2,882,1892025-09-15
Boulding Mark ElliottDerivatives Exercise47,2492025-09-15
SOUTHWELL DAVID PSale-12,000$58.34$700,0802025-09-11
SOUTHWELL DAVID PDerivatives Exercise12,0002025-09-11
Pauwels EricSale-39,850$56.94$2,269,0592025-09-09
Pauwels EricDerivatives Exercise39,8502025-09-09
Jacobson Allan StevenSale-1,667$50.15$83,6002025-09-02
Boulding Mark ElliottSale-2,813$48.58$136,6562025-08-19
Boulding Mark ElliottDerivatives Exercise2,8132025-08-19
Klein Matthew B.Sale-10,739$51.74$555,6362025-08-05
Klein Matthew B.Grant, award...etc75,0002025-08-05
Gravier PierreSale-2,516$49.46$124,4412025-07-17
Boulding Mark ElliottSale-2,812$46.18$129,8582025-05-19
Boulding Mark ElliottDerivatives Exercise2,8122025-05-19
Klein Matthew B.Sale-2,804$48.74$136,6562025-04-24
Golden Lee ScottSale-897$46.95$42,1142025-04-04
Pauwels EricSale-11,220$55.19$619,2322025-03-18
Okey StephanieSale-5,000$54$270,0002025-03-17
Boulding Mark ElliottSale-15,521$53.31$827,4252025-03-14
Boulding Mark ElliottDerivatives Exercise15,5212025-03-14
Boulding Mark ElliottSale-75,420$53.15$4,008,5732025-03-12
Boulding Mark ElliottDerivatives Exercise75,4202025-03-12
Jacobson Allan StevenSale-1,230$51.52$63,3702025-03-06
Golden Lee ScottSale-1,757$50.1$88,0192025-02-21
Almstead Neil GregorySale-68$50.1$3,4072025-02-21
Almstead Neil GregorySale-2,878$50.1$144,1762025-02-21
Boulding Mark ElliottSale-2,947$50.1$147,6332025-02-21
Klein Matthew B.Sale-7,792$50.1$390,3482025-02-21
Pauwels EricSale-2,945$50.1$147,5332025-02-21
Utter Christine MarieSale-1,757$50.1$88,0192025-02-21
Gravier PierreSale-2,335$50.1$116,9742025-02-21
Boulding Mark ElliottSale-3,541$45.34$160,5492025-01-10
Almstead Neil GregorySale-162$45.34$7,3452025-01-10
Almstead Neil GregorySale-2,817$45.34$127,7232025-01-10
Klein Matthew B.Sale-4,544$45.34$206,0252025-01-10
Golden Lee ScottSale-2,008$45.34$91,0432025-01-10
Utter Christine MarieSale-2,953$45.34$133,8892025-01-10
Pauwels EricSale-3,735$45.34$169,3452025-01-10
Boulding Mark ElliottGrant, award...etc18,0002025-01-07
Golden Lee ScottGrant, award...etc20,0002025-01-07
Almstead Neil GregoryGrant, award...etc7152025-01-07
Almstead Neil GregoryGrant, award...etc19,0002025-01-07
Pauwels EricGrant, award...etc22,0002025-01-07
Gravier PierreGrant, award...etc22,5002025-01-07
Klein Matthew B.Grant, award...etc70,0002025-01-07
Okey StephanieGrant, award...etc4,0002025-01-07
Utter Christine MarieGrant, award...etc14,0002025-01-07
Jacobson Allan StevenGrant, award...etc4,0002025-01-07
SCHMERTZLER MICHAELGrant, award...etc8,0002025-01-07
Young AlethiaGrant, award...etc4,0002025-01-07
ZELDIS JEROME BGrant, award...etc4,0002025-01-07
STEELE GLENN JR MD PHDGrant, award...etc4,0002025-01-07
Reeve EmmaGrant, award...etc4,0002025-01-07
Smith Mary L.Grant, award...etc4,0002025-01-07
SOUTHWELL DAVID PGrant, award...etc4,0002025-01-07
Klein Matthew B.Sale-8,279$45.16$373,8802025-01-03
Utter Christine MarieSale-17,800$51.34$913,8522024-12-04
Utter Christine MarieDerivatives Exercise17,8002024-12-04
Almstead Neil GregorySale-2,060$51.85$106,8112024-12-04
Almstead Neil GregoryDerivatives Exercise2,0602024-12-04
Almstead Neil GregorySale-69,550$51.85$3,606,1682024-12-04
Almstead Neil GregoryDerivatives Exercise69,5502024-12-04
Boulding Mark ElliottSale-95,908$52.17$5,003,5202024-12-04
Boulding Mark ElliottDerivatives Exercise95,9082024-12-04
ZELDIS JEROME BSale-24,000$51.44$1,234,5602024-12-04
ZELDIS JEROME BDerivatives Exercise24,0002024-12-04
Gravier PierreSale-2,269$34.02$77,2002024-07-18
ZELDIS JEROME BSale-20,000$38.24$764,8002024-05-24
ZELDIS JEROME BDerivatives Exercise20,0002024-05-24
Golden Lee ScottSale-175$32.82$5,7442024-05-08
Klein Matthew B.Sale-3,361$24.89$83,6692024-04-22
Klein Matthew B.Sale-1,307$25.14$32,8512024-04-19
Pauwels EricSale-787$25.14$19,7812024-04-19
Golden Lee ScottSale-526$28.37$14,9232024-04-04
Bell William F. Jr.Grant, award...etc4,0002024-02-16
Okey StephanieGrant, award...etc4,0002024-02-16
SOUTHWELL DAVID PGrant, award...etc4,0002024-02-16
Golden Lee ScottGrant, award...etc22,6002024-02-16
Gravier PierreGrant, award...etc22,1002024-02-16
Boulding Mark ElliottGrant, award...etc21,2002024-02-16
Klein Matthew B.Grant, award...etc70,0002024-02-16
Reeve EmmaGrant, award...etc4,0002024-02-16
Jacobson Allan StevenGrant, award...etc4,0002024-02-16
Young AlethiaGrant, award...etc4,0002024-02-16
ZELDIS JEROME BGrant, award...etc4,0002024-02-16
STEELE GLENN JR MD PHDGrant, award...etc4,0002024-02-16
Smith Mary L.Grant, award...etc4,0002024-02-16
Utter Christine MarieGrant, award...etc16,9002024-02-16
SCHMERTZLER MICHAELGrant, award...etc8,0002024-02-16
Almstead Neil GregoryGrant, award...etc8702024-02-16
Almstead Neil GregoryGrant, award...etc25,0002024-02-16
Pauwels EricGrant, award...etc24,3002024-02-16
Pauwels EricSale-366$27.25$9,9742024-02-01
Utter Christine MarieSale-318$27.25$8,6662024-02-01
Boulding Mark ElliottSale-794$27.25$21,6372024-02-01
Almstead Neil GregorySale-28$27.25$7632024-02-01
Almstead Neil GregorySale-618$27.25$16,8412024-02-01
Jacobson Allan StevenSale-10,000$27.38$273,8042024-01-24
Jacobson Allan StevenDerivatives Exercise10,0002024-01-24
Login to see more insider transactions
The information provided in this report about PTCT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

PTC Therapeutics, Inc
(NASDAQ:PTCT) 

PTCT stock logo

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for the treatment of rare disorders. The company offers Translarna (ataluren) and Emflaza (deflazacort) for the treatment of nonsense mutation Duchenne muscular dystrophy in...

Founded: 1998
Full Time Employees: 754
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends